Psybio Therapeutics Corporation (CE) (PSYBF)
USOTC
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current PSYBF market cap is 13.26k. The company's latest EPS is USD -0.0368 and P/E is -0.27.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -52k | 0 | -19k | -6.52M | -2.69M |
| Net Income | -52k | -28k | -22k | -11.02M | -4.89M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | USD ($) | USD ($) | |
| Total Assets | 271k | 252k | 220k | 4.01M | 390k |
| Total Liabilities | 47k | 56k | 46k | 1.29M | 1.98M |
| Total Equity | 224k | 196k | 174k | 2.72M | -1.59M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | USD ($) | USD ($) | |
| Operating | -52k | -19k | -33k | -6.95M | -3.44M |
| Investing | N/A | N/A | N/A | -3.56M | 3.52M |
| Financing | -7k | N/A | N/A | 10.37M | -55k |
| Market Cap | 13.26k |
| Price to Earnings Ratio | -0.27 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 8.33 |
| Price to Book Ratio | -0.83 |
| Dividend Yield | - |
| Shares Outstanding | 132.61M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 3.46k |
| 52 Week Change | -99.47% |
| 52 Week High | 0.0236 |
| 52 Week Low | 0.0001 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Psybio Therapeutics Corporation (CE) |
| Address |
25th floor, 700 w georgia street vancouver, british columbia V7Y 1B3 |
| Website | https://www.psybiolife.com |
| Industry | unit inv tr, closed-end mgmt (6726) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
